Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00617097Phase 3Completed
Phase 3, randomised, double-blind trial of ketorolac in pain, sponsored by Johns Hopkins University. Primary endpoint: Pain During Specific Time Intervals Throughout D&C Procedure. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00617097.